Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

Standard

Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. / Scheja, Ludger; Makowski, L; Uysal, K T; Wiesbrock, S M; Shimshek, D R; Meyers, D S; Morgan, M; Parker, R A; Hotamisligil, G S.

in: DIABETES, Jahrgang 48, Nr. 10, 10, 1999, S. 1987-1994.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Scheja, L, Makowski, L, Uysal, KT, Wiesbrock, SM, Shimshek, DR, Meyers, DS, Morgan, M, Parker, RA & Hotamisligil, GS 1999, 'Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.', DIABETES, Jg. 48, Nr. 10, 10, S. 1987-1994. <http://www.ncbi.nlm.nih.gov/pubmed/10512363?dopt=Citation>

APA

Scheja, L., Makowski, L., Uysal, K. T., Wiesbrock, S. M., Shimshek, D. R., Meyers, D. S., Morgan, M., Parker, R. A., & Hotamisligil, G. S. (1999). Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. DIABETES, 48(10), 1987-1994. [10]. http://www.ncbi.nlm.nih.gov/pubmed/10512363?dopt=Citation

Vancouver

Scheja L, Makowski L, Uysal KT, Wiesbrock SM, Shimshek DR, Meyers DS et al. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. DIABETES. 1999;48(10):1987-1994. 10.

Bibtex

@article{d02466c50ff44c8dbf37a38572ae254e,
title = "Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.",
abstract = "Recent studies have shown that genetic deficiency of the adipocyte fatty acid-binding protein (aP2) results in minor alterations of plasma lipids and adipocyte development but provides significant protection from dietary obesity-induced hyperinsulinemia and insulin resistance. To identify potential mechanisms responsible for this phenotype, we examined lipolysis and insulin secretion in aP2-/- mice. Beta-adrenergic stimulation resulted in a blunted rise of blood glycerol levels in aP2-/- compared with aP2+/+ mice, suggesting diminished lipolysis in aP2-/- adipocytes. Confirming this, primary adipocytes isolated from aP2-/- mice showed attenuated glycerol and free fatty acid (FFA) release in response to dibutyryl cAMP. The decreased lipolytic response seen in the aP2-/- mice was not associated with altered expression levels of hormone-sensitive lipase or perilipin. The acute insulin secretory response to beta-adrenergic stimulation was also profoundly suppressed in aP2-/- mice despite comparable total concentrations and only minor changes in the composition of systemic FFAs. To address whether levels of specific fatty acids are different in aP2-/- mice, the plasma FFA profile after beta-adrenergic stimulation was determined. Significant reduction in both stearic and cis-11-eicoseneic acids and an increase in palmitoleic acid were observed. The response of aP2-/- mice to other insulin secretagogues such as arginine and glyburide was similar to that of aP2+/+ mice, arguing against generally impaired function of pancreatic beta-cells. Finally, no aP2 expression was detected in isolated pancreatic islet cells. These results provide support for the existence of an adipo-pancreatic axis, the proper action of which relies on the presence of aP2. Consequently, aP2's role in the pathogenesis of type 2 diabetes might involve regulation of both hyperinsulinemia and insulin resistance through its impact on both lipolysis and insulin secretion.",
author = "Ludger Scheja and L Makowski and Uysal, {K T} and Wiesbrock, {S M} and Shimshek, {D R} and Meyers, {D S} and M Morgan and Parker, {R A} and Hotamisligil, {G S}",
year = "1999",
language = "Deutsch",
volume = "48",
pages = "1987--1994",
journal = "DIABETES",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "10",

}

RIS

TY - JOUR

T1 - Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

AU - Scheja, Ludger

AU - Makowski, L

AU - Uysal, K T

AU - Wiesbrock, S M

AU - Shimshek, D R

AU - Meyers, D S

AU - Morgan, M

AU - Parker, R A

AU - Hotamisligil, G S

PY - 1999

Y1 - 1999

N2 - Recent studies have shown that genetic deficiency of the adipocyte fatty acid-binding protein (aP2) results in minor alterations of plasma lipids and adipocyte development but provides significant protection from dietary obesity-induced hyperinsulinemia and insulin resistance. To identify potential mechanisms responsible for this phenotype, we examined lipolysis and insulin secretion in aP2-/- mice. Beta-adrenergic stimulation resulted in a blunted rise of blood glycerol levels in aP2-/- compared with aP2+/+ mice, suggesting diminished lipolysis in aP2-/- adipocytes. Confirming this, primary adipocytes isolated from aP2-/- mice showed attenuated glycerol and free fatty acid (FFA) release in response to dibutyryl cAMP. The decreased lipolytic response seen in the aP2-/- mice was not associated with altered expression levels of hormone-sensitive lipase or perilipin. The acute insulin secretory response to beta-adrenergic stimulation was also profoundly suppressed in aP2-/- mice despite comparable total concentrations and only minor changes in the composition of systemic FFAs. To address whether levels of specific fatty acids are different in aP2-/- mice, the plasma FFA profile after beta-adrenergic stimulation was determined. Significant reduction in both stearic and cis-11-eicoseneic acids and an increase in palmitoleic acid were observed. The response of aP2-/- mice to other insulin secretagogues such as arginine and glyburide was similar to that of aP2+/+ mice, arguing against generally impaired function of pancreatic beta-cells. Finally, no aP2 expression was detected in isolated pancreatic islet cells. These results provide support for the existence of an adipo-pancreatic axis, the proper action of which relies on the presence of aP2. Consequently, aP2's role in the pathogenesis of type 2 diabetes might involve regulation of both hyperinsulinemia and insulin resistance through its impact on both lipolysis and insulin secretion.

AB - Recent studies have shown that genetic deficiency of the adipocyte fatty acid-binding protein (aP2) results in minor alterations of plasma lipids and adipocyte development but provides significant protection from dietary obesity-induced hyperinsulinemia and insulin resistance. To identify potential mechanisms responsible for this phenotype, we examined lipolysis and insulin secretion in aP2-/- mice. Beta-adrenergic stimulation resulted in a blunted rise of blood glycerol levels in aP2-/- compared with aP2+/+ mice, suggesting diminished lipolysis in aP2-/- adipocytes. Confirming this, primary adipocytes isolated from aP2-/- mice showed attenuated glycerol and free fatty acid (FFA) release in response to dibutyryl cAMP. The decreased lipolytic response seen in the aP2-/- mice was not associated with altered expression levels of hormone-sensitive lipase or perilipin. The acute insulin secretory response to beta-adrenergic stimulation was also profoundly suppressed in aP2-/- mice despite comparable total concentrations and only minor changes in the composition of systemic FFAs. To address whether levels of specific fatty acids are different in aP2-/- mice, the plasma FFA profile after beta-adrenergic stimulation was determined. Significant reduction in both stearic and cis-11-eicoseneic acids and an increase in palmitoleic acid were observed. The response of aP2-/- mice to other insulin secretagogues such as arginine and glyburide was similar to that of aP2+/+ mice, arguing against generally impaired function of pancreatic beta-cells. Finally, no aP2 expression was detected in isolated pancreatic islet cells. These results provide support for the existence of an adipo-pancreatic axis, the proper action of which relies on the presence of aP2. Consequently, aP2's role in the pathogenesis of type 2 diabetes might involve regulation of both hyperinsulinemia and insulin resistance through its impact on both lipolysis and insulin secretion.

M3 - SCORING: Zeitschriftenaufsatz

VL - 48

SP - 1987

EP - 1994

JO - DIABETES

JF - DIABETES

SN - 0012-1797

IS - 10

M1 - 10

ER -